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Abstract

Article History:

Purpose: Acute pancreatitis (AP) is an inflammatory disorder distinguished by tissue injury
and inflammation of the pancreas. Using paracrine potential of mesenchymal stem cells
(MSCs) provides a useful clinical approach in treating inflammatory diseases. We investigated
the therapeutic effects of adipose-derived MSC conditioned medium (CM) and hypoxia
preconditioned adipose-derived MSC conditioned medium (HCM) in cerulein-induced AP in
mice.
Methods: AP was induced in C57BL/6 mice by intraperitoneal injection of cerulein (75 μg/
kg/h × 7 times). One hour following the last injection of cerulein, mice were treated with
intraperitoneal injection of CM and HCM (500 µL/mice/30 min × 3 times). Twelve hours
following the treatment, serum levels of amylase and lipase were measured. In addition,
pancreas pathological changes, immunohistochemical examinations for evaluation of IL-6
expression and pancreatic myeloperoxidase (MPO) enzyme activity were analyzed.
Results: The in vitro results of the morphological, differentiation and immunophenotyping
analyses confirmed that hypoxia preconditioned MSCs (HP-MSCs) conserve MSCs characteristics
after preconditioning. However, HP-MSCs significantly expressed high mRNA level of hypoxia
inducible factor 1-α and higher level of total protein. The in vivo findings of the current study
showed that CM and HCM significantly reduced the amylase & lipase activity, the severity of
pancreas tissue injury and the expression of IL-6 and MPO enzyme activity compared with the
AP group. However, no significant difference between CM and HCM groups was demonstrated.
Conclusion: Use of CM and HCM can attenuate cerulein-induced AP and decrease inflammation
in the pancreas tissue in AP mice.
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Introduction
Acute pancreatitis (AP) is a gastrointestinal inflammatory
disease characterized by acinar cells injury and
inflammation in pancreatic tissue. AP is the most common
cause of hospital stays among gastrointestinal diseases.1,2
Clinical manifestation of AP ranges from mild (80%-85%)

to severe forms (15%-20%). Gallstone and alcohol abuse
are two major causes for AP.1-3
Previous studies have demonstrated acinar cell death,
edema and histopathological changes induced by the
activation and release of pancreatic enzymes in early
phases of pancreatitis.4-6 Along with pancreatic enzyme
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activation (trypsin, amylase, lipase), activation of NFKB also occurs in acinar cells.5 Moreover, inflammatory
mediators—including tumor necrosis factor alpha
(TNF-α), interleukin 1 beta (IL-1β), IL-6, IL-33,
chemokines and neutrophilic myeloperoxidase (MPO),
which are produced by immune cells and injured acinar
cells—can exacerbate the inflammatory cascade in the AP
patients.3,5,7-13
Currently, endoscopic retrograde cholangiopancreatography
(ERCP), non-steroidal anti-inflammatory drugs (NSAIDs),
use of prophylactic antibiotics and enteral nutrition are
the available treatment options for AP. Nevertheless, the
mortality rate of the severe stage of AP is around 30%.2,9
These strategies chiefly target the symptoms rather than
the cause of the disease; therefore, the development of
new treatment approaches, such as cell-based therapy, is
required for more efficient management of this complicated
gastrointestinal disease.2,9,14,15
Mesenchymal stem cells (MSCs) and their secreted
molecules—which possess regenerative, anti-inflammatory
and antioxidative properties—have been suggested as a
potential therapeutic approach in many inflammatory and
immune-mediated disorders.16-22
Jung et al, for the first time in 2011, reported the protective
effects of MSCs in treating AP.23 Subsequently, several
studies demonstrated that MSC therapy can decrease
inflammatory mediators and mitigate histopathological
changes in pancreatitis through direct differentiation
to acinar cells or indirect immunomodulatory effects.
Nevertheless, clinical trial studies have not yet been
performed to evaluate the effects of MSC therapy in AP.24-26
The strong paracrine activity of MSCs is a usable
capability to treat many autoimmune and inflammatory
disorders.20,27,28 Recent studies reported the protective
effects of MSC-derived conditioned medium (MSC-CM)
or MSC-derived extracellular vesicles (MSC-EVs) in some
animal models of diseases.17,20,22,27,29,30 Proteomics analysis
of MSC-CM has identified more than 100 proteins
(including cytokines, chemokines and growth factors)
with anti-inflammatory, anti-apoptotic, anti-fibrotic and
regenerative effects.28,31
It has been shown that exposure of MSCs to hypoxic
conditions might enhance their immunomodulatory
and regenerative properties via over-expression of
cytoprotective genes and secretory factors.28,32 Hypoxia
inducible factor 1-α (HIF-1α) has a crucial role in
regard to the upregulation of these genes and factors.33,34
Accordingly, hypoxia preconditioned MSCs can attenuate
inflammation, tissue injury and fibrosis in some of the
experimental animal models.34,35
To our knowledge, the protective effects of adiposederived MSC (AD-MSC) conditioned medium (CM)
and hypoxia preconditioned adipose-derived MSC
conditioned medium (HCM) have not yet been
investigated in the therapy of AP. Therefore, this study
investigates the therapeutic effects of CM and HCM,
298
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which are assessed in mice with cerulein-induced AP.
Materials and Methods
Animals
Male C57BL/6 mice (6-8 weeks, 18-25 g) were obtained
from the Pasteur Institute of Tehran, Iran. The mice were
kept under standardized animal housing conditions.
Isolation, culture and characterization of AD-MSCs
Epididymal adipose tissue of C57BL/6 mice was removed
and homogenized using 0.1% collagenase type I (Gibco,
UK). Isolation and culture of AD-MSCs were performed
as previously described.29 Briefly, the adipose tissue was
homogenized in DMEM/F12 (Gibco, UK) and centrifuged
at 1500 rpm for 15 minutes. The pellet was suspended in
DMEM/F12 with 10% FBS (Gibco, UK), 100 U/mL of
penicillin and 100 µg/mL of streptomycin. AD-MSCs
were incubated in the standard cell culture conditions.
After obtaining of 70%-80% confluency, MSCs were
trypsinized using trypsin 0.05% (Sigma, USA) and 0.02%
EDTA, then subcultured. Characterization of MSCs was
performed by morphological evaluation, differentiation
assay and flow cytometry analysis at the second passage.
Characterization of AD-MSCs with differentiation assay
Differentiation potency of AD-MSCs into osteocyte and
adipocyte lineage was assessed by culturing in osteogenic
differentiation media (containing glycerol phosphate (10
mM), dexamethasone (100 mM) and ascorbic acid‐2
phosphate (5 g/mL)) and adipogenic differentiation
media (containing indomethacin (100 mM), 3‐isobutyl‐
methylxanthine (0.5 mM), dexamethasone (250 mM)
and insulin (5 mM)) for 3 weeks. Finally, mineralization
of osteocytes was identified by staining with Alizarin
Red S, and entity of oil vacuoles in the adipocytes was
evaluated by Oil Red O staining. Briefly, media was
discarded and MSCs were rinsed by phosphate-buffered
saline (PBS). Paraformaldehyde (4%) was used for cell
fixation (20 min/4ºC); then after washing with PBS, MSCs
were stained with 2% Alizarin Red S and 0.5% Oil Red O
solution, respectively (10 min/RT).17,29
Characterization of AD-MSCs with flow cytometry
analysis
Surface markers for MSCs characterization were analyzed
using monoclonal anti-mouse antibodies, including
anti‐CD44-FITC (561859 BD Biosciences), anti‐CD105PerCP Cy5.5 (120415 BioLegend), anti‐CD34-PE
(551389 BD Biosciences) and anti‐CD45-FITC (553079
BD Biosciences), along with isotype control antibodies.
Preparation of samples for immunophenotyping analysis
was performed as previously described.29 The samples
were assessed using BD FACS Calibur flow cytometer (BD
biosciences, San Jose, CA, USA) and analyzed by FlowJo
7.6 software.

Effect of hypoxia preconditioned AD-MSC-CM on acute pancreatitis

Hypoxic preconditioning and characterization of
hypoxia preconditioned-MSCs (HP-MSCs)
AD-MSCs with 70%-80% confluency at second passage
were cultured under hypoxic conditions (2-5% oxygen
concentration, 5% CO2 concentration and balanced N2) for
48 hours. HP-MSCs were characterized by morphological
evaluation, differentiation assay and flow cytometry
analysis as previously described.
Identification of HP-MSCs by real-time PCR
To identify the effects of hypoxic preconditioning, mRNA
expression level of HIF-1α was analyzed using quantitative
real-time PCR. Total RNA was extracted from the ADMSCs under standard and hypoxic cell culture conditions
by RNA X plus (Sina Clone Co., Tehran, Iran). Next, cDNA
synthesis was performed using the random hexamer
primer, dNTP and M-MLV reverse transcriptase enzyme
(Yekta Tajhiz Co., Tehran, Iran). The real-time PCR was
completed with the Applied Biosystems StepOnePlus™
system, using SyberGreen Master Mix (Sina Clone Co.,
Tehran, Iran) and mouse HIF-1α specific primers. Realtime PCR was conducted with the following conditions:
initial denaturation stage (95°C/2 min), cycling stage
(95°C/5 s and 60°C for 30 seconds, 40 cycles) and melt
curve stage (95°C/15 s, 60°C for 1 minute and 95°C/15
s). The mitochondrial ribosomal protein S16 (MRPS16)
mRNA expression level of a reference mouse was used
for normalization. The relative gene expression was
calculated by the ΔΔCt method. Mouse gene-specific
primers sequences are listed in Table 1.
Preparation and total protein assay of CM & HCM
Conditioned medium preparation protocol has been
reported in several previous studies.17,22,36 Briefly, ADMSCs at second passage with 70%-80% confluency
were incubated in serum-free DMEM/F12 media under
standard and hypoxic conditions. After 48 hours, the CM
of AD-MSCs and HP-MSCs was collected. CM and HCM
were centrifuged (1500 rpm for 5 minutes), filtered (0.22
µm filter), stored (-80°C) and utilized for injection into
experimental groups in the treatment procedures.
Before the treatment procedures, the total protein
concentration of CM and HCM was measured using the
Pierce™ BCA protein assay kit (Thermo Fisher Scientific,
Waltham, MA). Optical density (OD) measurements were
performed at 570 nm, and the protein concentration of
CM and HCM was calculated by standard curve obtained
from serial dilutions of bovine serum albumin (BSA). The
results were reported in µg/mL.
Table 1. Mouse gene-specific primers sequences
Gene
name

Primer sequence (5’………3’)

HIF-1α

Forward: TTGGCAGCGATGACACA
NM_001313919.1
Reverse: CGATGAAGGTAAAGGAGACATT

MRPS16

Forward: TCGGACGCAAGAAAACAG
Reverse: CCACCACCCTTCACACG

Accession number

NM_013647.2

Induction of disease, experimental grouping and
treatment procedure
Male C57BL/6 mice were induced with AP at 6-8 weeks-old
by intraperitoneal (i.p.) injection of cerulein, as previously
described.9 Briefly, mice received seven injections of 75
μg/kg cerulein (C9026 Sigma-Aldrich) dissolved in 200
µL sterile saline at hourly intervals intraperitoneally.
Forty-two mice were divided into six experimental groups
(n = 7 mice/group). The normal group (Normal) received
sterile normal saline (200 µL/h × 7 times, i.p.). The AP
group received cerulein injections (75 µg/kg/h, dissolved
in 200 µL sterile normal saline, i.p.). One hour after the
last cerulein injection, Normal and AP experimental
groups received injections of 1.5 mL sterile PBS (500 µL/
mice/30 min × 3 times, i.p.).
For the treatment procedure, (AP+CM) and
(Normal+CM) experimental groups were treated
with injection of 1.5 mL CM (500 µL/mice/30 min × 3
times, i.p.). Two other groups of mice—(AP+HCM)
and (Normal+HCM)—were treated with HCM. Twelve
hours after treatment, all mice in the experimental
groups were euthanized. Under the sterile conditions,
pancreatic tissues were quickly removed for evaluation
of MPO enzyme activity, along with histopathological
and immunohistochemical examinations. Whole blood
samples were obtained to evaluate levels of amylase and
lipase (Figure 1).
Determination of levels of serum amylase and lipase
Determination of amylase and lipase, along with
histopathological examinations, were used for
characterization of AP induction in experimental animal
models and evaluation of treatment effects. The blood
samples were centrifuged at 2500 rpm for 10 minutes at
4°C. Serum samples were stored at -80°C in an ultra-low
temperature freezer (New Brunswick, Eppendorf Co.). A
biochemistry autoanalyzer (Roche Hitachi 917) measured
serum levels of amylase and lipase using the calorimetric
method (Pars Azmoon Co., Tehran, Iran).
Histopathological examination
At the end of the experimental procedure, a part of the
pancreatic tissue was used for the histopathological
examination. After washing with PBS, pancreatic samples
were fixed in 10% buffered formaldehyde following
the histopathological processing,9,37 and stained with
hematoxylin and eosin (H&E) to investigate acinar cell
vacuolization, leukocyte infiltration, acinar cell necrosis,
edema, and hemorrhage. Finally, the pancreatic tissue
sections were examined using the optical microscope at
100X and 400X. Six sections per tissue and seven animals
per group were analyzed.
Immunohistochemical examination
The pancreatic sections collected from the experimental
groups were immunostained with IL-6, which is an
Advanced Pharmaceutical Bulletin, 2020, Volume 10, Issue 2

299

Abdolmohammadi et al

Figure 1. Study design for AP induction, treatment procedure, in vitro and in vivo experiments. Abbreviations: AD-MSCs: adipose-derived mesenchymal stem cells,
AP: acute pancreatitis, CM: adipose-derived MSC conditioned medium, HCM: hypoxia preconditioned adipose-derived MSC conditioned medium, HP-MSCs:
hypoxia preconditioned mesenchymal stem cells, i.p.: intraperitoneal.

important inflammatory biomarker in AP. Briefly, after
deparaffinization (65-70ºC for 30 minutes) and hydration,
antigen retrieval was performed using Universal HIER Ag
Retrieval Reagent (Abcam Biotechnology Co., ab208572)
(95°C for 20-60 minutes). The samples were blocked
using blocking buffer (goat serum, BSA, Tween 20, Triton
X100, PBS) (37°C for 60 minutes), then incubated with
rabbit polyclonal antibody of anti-mouse IL-6 (Abcam
Biotechnology Co., ab208113) (1:200 in PBS+1% BSA)
overnight at 4°C. Endogenous peroxidase of tissue
samples was quenched with 0.3% hydrogen peroxide
(15-20 minutes at dark room). Following washing with
PBS, sections were detected with a sheep anti-rabbit
Ig secondary antibody conjugated to HRP (Padza Co.,
Tehran, Iran, pz5684) (1:500 in PBS+1% BSA), then a
solution of 0.1% 3, 3-diaminobenzidine and 0.02% H2O2.
Finally, the samples were stained with hematoxylin and
prepared after dehydration and mounting. The samples
were examined using the optical microscope at 100X and
400X. Six sections per tissue and seven animals per group
were analyzed by ImageJ Software.
Evaluation of myeloperoxidase enzyme activity
Pancreas MPO enzyme level was measured by the MPO
assay kit (NampoxTM, Navand Salamat Co., Uremia,
Iran), according to the standard protocol. Briefly,
frozen pancreatic tissue samples were weighed and
homogenized in sample buffer 1X (pH=6.0) containing
0.5% hexadecyl trimethyl ammonium bromide. The
samples were centrifuged at 10 000 rpm for 10 minutes in
4°C. Absorbance measurements were recorded at 450 nm
in the supernatant using TMB and H2O2. The results of
MPO assay were reported as the OD/mg tissue.38
Statistical analysis
Data was analyzed using GraphPad Prism 5 software,
and experimental groups were compared using one-way
300
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ANOVA with Tukey’s multiple comparison or Student’s t
test statistical analysis. Data was presented as a mean ±
standard deviation (SD). A P value < 0.05 was set as the
statistical significance level.
Results and Discussion
AD-MSCs and HP-MSCs characterization by
morphological evaluation, differentiation assay and
flow cytometry analysis
Morphological evaluation of MSCs and HP-MSCs showed
typical spindle-shaped fibroblast-like adherent cells after
in vitro expansion using the inverted phase-contrast
microscopy (Figure 2A, B).
Following 3 weeks of culture in the differentiation
media, the osteogenic and adipogenic potency of MSCs
and HP-MSCs were confirmed using Alizarin Red S and
Oil Red O, respectively. The results of differentiation
assay revealed that MSCs and HP-MSCs did not vary
in their differentiation into osteoblasts and adipocytes
(Figure 2C-F).
According to the recommended criteria for the definition
of MSCs,39 immunophenotyping analysis of MSCs and HPMSCs showed that both MSCs and HP-MSCs expressed
low levels of hematopoietic surface markers—like CD34
and CD45—while these cells expressed increased levels
of mesenchymal surface markers—including CD44 and
CD105. The percentage of each surface marker in MSCs
and HP-MSCs is presented in Figure 2G. The results of
the morphological evaluation, differentiation potency
assay and immunophenotyping analysis showed that
HP-MSCs preserve MSC characteristics after hypoxic
preconditioning (2%-5% O2 for 48 hours).
Hypoxic preconditioning verification by the mRNA
expression level of HIF-1α
To verify the effect of hypoxia on MSCs, the mRNA
expression level of HIF-1α was analyzed in AD-MSCs and

Effect of hypoxia preconditioned AD-MSC-CM on acute pancreatitis

Figure 2. HP-MSCs preserve mesenchymal stem cell characteristics after hypoxic preconditioning (2-5% O2 for 48 h). Representative images of MSCs (a) and HPMSCs (b) by a phase-contrast microscope. Osteogenic (c, d) and adipogenic (e, f) differentiation potential of MSCs and HP-MSCs after staining by Alizarin Red
S and Oil Red O, respectively. The expression level of mesenchymal stem cell surface markers on MSCs and HP-MSCs was analyzed by flow cytometry analysis
(g). All experiments were performed at the second passage. Abbreviations: HP-MSC: hypoxia preconditioned mesenchymal stem cell, MSC: adipose-derived
mesenchymal stem cell.

HP-MSCs by real-time PCR. Results showed that MSCs
cultured in hypoxic conditions (HP-MSC) significantly
expressed a high level of HIF-1α in comparison to the
MSCs cultured in standard conditions (MSC) (3.98-fold,
P < 0.05) (Figure 3A). To obtain these results, three series
of cultured MSCs and HP-MSCs were extracted and
analyzed.
Total protein assay of CM and HCM
After 48 hours incubation of MSCs under standard and
hypoxic conditions in serum-free DMEM/F12 media,
protein concentration in MSC and HP-MSC derived CM
were calculated using the Pierce™ BCA protein assay kit.
The results demonstrated that MSCs cultured for 48 h
in hypoxic conditions (HP-MSC) produced significantly

higher (P < 0.05) levels of proteins compared to MSCs
cultured in standard conditions (MSC) (Figure 3B).
In vitro pre-conditioning can improve the effects of
MSC and CM via over-expression of cytoprotective
genes.34,40,41 Some notable studies demonstrated that
hypoxic preconditioning increases the expression level of
HIF-1α, which acts an important gene in the upregulation
of cytoprotective factors. Previous studies reported that
hypoxic conditions modulate the paracrine activity,
upregulates the secretable factors and increases the protein
levels of HP-MSCs similar to that of MSCs cultured in the
normal conditions.32,42
Our in vitro findings demonstrate that hypoxic
preconditioning of adipose-derived MSCs (2-5% O2 for 48
hours) does not change the morphology, differentiation

Figure 3. Hypoxic preconditioning (2-5% O2 for 48 h) increases the expression of HIF-1α in HP-MSCs and total protein concentration in HCM. Expression level of
HIF-1α (a) was analyzed by real-time PCR. HP-MSC expresses a high level (3.98-fold) of HIF-1α in comparison to the MSC (*P < 0.05). Total protein concentration
(b) was measured by BCA protein assay kit. HP-MSCs produces higher levels (1.31-fold) of proteins compared to MSCs cultured in standard conditions (*P < 0.05).
All experiments were analyzed in three series. Abbreviations: CM: adipose-derived MSC conditioned medium, HCM: hypoxia preconditioned adipose-derived
MSC conditioned medium, HIF-1α: hypoxia inducible factor 1-α, HP-MSCs: hypoxia preconditioned mesenchymal stem cells.
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potency or phenotyping characteristics of MSCs (Figure
2), yet it significantly increases the expression of HIF1α in HP-MSCs and total protein concentration in CM
derived from HP-MSCs (Figure 3).
Effect of CM and HCM on serum amylase and lipase
levels
One of the criteria for diagnosing AP is elevated levels of
amylase and lipase.2,13,43 The cerulein-induced AP mice
(AP group) is characterized by a significantly higher level
of serum amylase and lipase (P < 0.001, Figure 4A, B).
As demonstrated in Figure 4A and 4B, intraperitoneal
injection of CM and HCM significantly reduced levels of
amylase and lipase activity compared with the AP group
(P < 0.05, P < 0.01, P < 0.001). There was no statistically
significant difference in levels of amylase and lipase
between the Normal mice compared to the Normal+CM
and Normal+HCM mice.
Despite the progression in understanding the
immunopathological mechanisms of AP, there is still no
satisfactory approach for curing this inflammatory disease,
as current approaches for the treatment of AP chiefly
target the symptoms rather than relieving pancreatic tissue
injury.1,2,5,6,9,11,13,44,45 Therefore, an efficient therapeutic
approach with an anti-inflammatory and regenerative
potential is useful for the treatment of AP patients. In this
research, we aimed to explore the therapeutic effect of CM
and HCM of AD-MSCs in an experimental model of AP.
Previous studies recommend that the use of MSCs
can mitigate experimental AP, inhibit inflammation
and ameliorate pancreas tissue damage.23-25 MSC-based
therapy utilizing all the MSC components faces some
obstacles, such as survival rate of transplanted cells and
ethical concerns.22,29,46 Regarding the limitations of MSC
use in the treatment of AP, there is no warranted clinical
trial in the therapy of AP.24,25 Some studies reported the
anti-inflammatory and regenerative effects of MSCderived CM.17,22,36 Proteomics analysis of MSC-CM
showed several cytokines, chemokines and growth factors
with anti-inflammatory, anti-apoptotic, anti-fibrotic
and regenerative properties.28,31 Therefore, it seems that
CM, as a multi-functional drug, can be a suitable and
simplified new approach for the treatment of AP. Similar
to other studies that reported the anti-inflammatory and
regenerative effects of MSC in animal models of AP,24,25 our
in vivo results show that CM and HCM can significantly
decrease the serum amylase and, especially, lipase levels
(Figure 4A, B).
Effect of CM and HCM on histopathological findings
Acinar cell injury and inflammatory cell accumulation
are the essential indicators to determine the severity of
tissue damage in AP.3,9 Histopathological results showed
that cerulein significantly lead to tissue injury and
leukocyte infiltration in pancreatic tissue of AP mice
(Figure 5G, H) compared to the Normal group (Figure
302
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Figure 4. CM and HCM injections decrease serum amylase and, especially,
lipase levels in AP mice. A biochemistry autoanalyzer was used for measuring
serum levels of amylase (a) and lipase (b). Data is expressed as mean ± SEM
(n=7). One-way ANOVA test was used for comparing differences between
experimental groups. *P < 0.05, **P < 0.01, ***P < 0.001. Abbreviations: AP:
acute pancreatitis, CM: adipose-derived MSC conditioned medium, HCM:
hypoxia preconditioned adipose-derived MSC conditioned medium.

5A, B). After treatment of AP mice with CM (Figure 5I,
J) and HCM (Figure 5K, L), leukocyte infiltration and
acinar cell vacuolization were significantly reduced in
the treated groups as compared to the AP group (Figure
5M, N). However, there was no significant difference in
the acinar cell necrosis, edema and hemorrhage between
experimental groups (Supplementary file 1, Figures S1-S3).
Histopathological findings of the current study
demonstrated that CM and HCM can attenuate acinar
cell vacuolization and decrease the leukocyte infiltration
in cerulein-induced AP (Figure 5). Because of the
short time period between treatment intervention and
histopathological examination, it seems the antiinflammatory effects of the CM and HCM are more
obvious than the regenerative effects. MSC-CM includes
many anti-inflammatory mediators—mainly PGE2,
IDO, HGF, TGF-β and IL-10—which can inhibit the
inflammatory cascade and tissue injury in several
inflammatory diseases.17,22,36,47
Effect of CM and HCM on immunohistochemical findings
Immunohistochemical staining results showed a high
expression of IL-6 in the parenchyma areas of pancreatic
tissues in AP mice (Figure 6G, H) compared to the
Normal group (Figure 6A, B). Treatment with CM (Figure
6I, J) and HCM (Figure 6K, L) significantly decreased the

Effect of hypoxia preconditioned AD-MSC-CM on acute pancreatitis

Figure 5. CM and HCM injections attenuate acinar cell vacuolization and
decrease the leukocyte infiltration in the pancreatic tissue of AP mice (il). Cerulein significantly leads to tissue injury and leukocyte infiltration
in pancreatic tissue of AP mice (g, h) compared to the Normal group (a,
b). Hematoxylin and eosin (H&E) staining was used for histopathological
evaluations using the optical microscope at 100X and 400X. The results
of microscopic examination are reported as a percentage of acinar cell
vacuolization (m), leukocyte infiltration (n), acinar cell necrosis, edema and
hemorrhage (Figures S1-S3). One-way ANOVA test was used for comparing
differences between experimental groups. *P < 0.05, **P < 0.01, ***P <
0.001. Abbreviations: AP: acute pancreatitis, CM: adipose-derived MSC
conditioned medium, HCM: hypoxia preconditioned adipose-derived MSC
conditioned medium.

Figure 6. CM and HCM injections reduce the expression of IL-6 in the
parenchyma areas in the pancreatic tissues of AP mice (i-l) compared to the AP
group (g, h). CM and HCM injection to the Normal mice does not significantly
affect the increase or decrease of IL-6 expression (a-f). Immunohistochemical
(IHC) staining was used for IL-6 expression examination after the treatment.
The samples were examined using the optical microscope at 100X and
400X. The results of six sections per tissue and seven animals per group
were analyzed by Image J Software (m). One-way ANOVA test was used for
comparing differences between experimental groups. *P < 0.05, **P < 0.01,
***P < 0.001. Abbreviations: AP: acute pancreatitis, CM: adipose-derived
MSC conditioned medium, HCM: hypoxia preconditioned adipose-derived
MSC conditioned medium.

expression of this pro-inflammatory cytokine compared
to the AP group (Figure 6M). CM and HCM injection to
the Normal mice did not significantly affect the increase
or decrease of IL-6 expression (Figure 6C-F).
Numerous animal models of AP have been generated to
study pathogenic mechanisms and investigate therapeutic
approaches in AP. Experimental AP has been created by
cerulein, sodium taurocholate (Na TCA), L-arginine,
choline-deficient diet and autoimmune pancreatitis
models. Cerulein-induced experimental AP is the most
frequently used AP model, and is similar to human
disease.23, 24 In the present study, we utilize the ceruleininduced model to evaluate the ability of CM and HCM
in the treatment of AP. Cerulein induces high levels of
reactive oxygen species and cytokines production, such
as IL-6 in acinar cells by NF-KB stimulation.44 Previous
studies showed that there is a positive correlation between
levels of IL-6 and severity of AP.48,49 In our AP model,
immunohistochemical results demonstrate significant
reduction in expression of IL-6 after treatment with CM
and HCM (Figure 6). In agreement with the current study,
Tu et al demonstrated that MSCs with anti-inflammatory

effects can mitigate severe AP in rats via decreasing the
expression of inflammatory cytokines, like IL-6.50
Effect of CM and HCM on MPO enzyme activity
Cerulein regulates infiltration, while inflammatory cell
activation mainly affects innate immune cells, such as
neutrophils within the pancreatic tissue.51 MPO is one
of the principal enzymes in the azurophilic granules of
leukocytes, especially neutrophils. Therefore, evaluation
of MPO enzyme level shows the presence and activity
of neutrophils within the inflamed tissue.8 As shown in
Figure 7, the levels of MPO enzyme were significantly
increased in the pancreas of AP mice compared to the
Normal mice (P < 0.01). Mice that were treated with HCM
demonstrate significantly reduced levels of MPO enzyme
compared to the AP group (P < 0.05). But, there was no
significant difference in the MPO levels after treatment
with CM.
Several studies demonstrated that cerulein regulates
infiltration and activation of inflammatory cells—mainly
innate immune cells—within the pancreatic tissue via
upregulation of intercellular adhesion molecule-1 in
Advanced Pharmaceutical Bulletin, 2020, Volume 10, Issue 2
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future studies in this field.
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Figure 7. Mice treated with HCM demonstrate significantly reduced levels
of MPO enzyme compared to the AP group. However, there is no significant
difference in the MPO levels after treatment with CM. MPO enzyme activity
was measured by the MPO assay kit and OD measurements were recorded
at 450 nm. The results are reported as the OD/mg tissue. Data is expressed as
mean ± SEM (n=7). One-way ANOVA test was used for comparing differences
between experimental groups. *P < 0.05, **P < 0.01. Abbreviations: AP:
acute pancreatitis, CM: adipose-derived MSC conditioned medium, HCM:
hypoxia preconditioned adipose-derived MSC conditioned medium, MPO:
myeloperoxidase, OD: optical density.

pancreatic acinar cells surface.51 Neutrophils and MPO
within their azurophilic granules play an important role in
the immunopathogenesis of AP.4,7,8,14,15 Our investigation
presents for the first time that intraperitoneal injection of
HCM, unlike CM, can decrease the MPO enzyme level in
AP mice (Figure 7).
Previous in vivo studies demonstrated that hypoxic
preconditioning of MSCs can promote their antiinflammatory and regenerative effects in some
experimental animal models.28,32,34,35 However, our in vivo
findings revealed that there was no significant difference
between the effect of CM and HCM on serum amylase
and lipase levels, pathological changes, IL-6 expression or
MPO enzyme level in the cerulein-induced AP (Figures
4-7). We used a single dose of CM and HCM in the current
study. Some previous studies demonstrated that repeated
doses of MSCs-derived CM are more effective compared
to the single dose,52 so future investigations involving a
dose-dependent manner can be helpful for understanding
this issue in the AP animal models. In addition to assay
total protein concentration, specific protein assay and
factor discovery in the HCM can be the next step for
evaluating the HCM effects in the immunopathogenesis
of AP. Intravenous versus intraperitoneal injection of CM
and HCM may also have different effects in the outcome
of AP. Finally, use of different animal models of AP will
provide additional insights into the effects of CM and
HCM in the therapy of AP.
Conclusion
In brief, we showed that injection of CM of MSCs and
HP-MSCs attenuates AP and reduces inflammation in
cerulein-induced AP in mice. Therefore, use of CM and
HCM can be considered as a cell-free treatment in the
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